AngioDynamics Financial Statements From 2010 to 2026

ANGO Stock

USD 10.56 0.50 4.97%

AngioDynamics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing AngioDynamics' valuation are provided below:

Gross Profit

167.7 M

Profit Margin

(0.09)

Market Capitalization

435.3 M

Enterprise Value Revenue

1.287

Revenue

307.3 M

We have found one hundred twenty available fundamental signals for AngioDynamics, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate AngioDynamics' prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 7th of February 2026, Market Cap is likely to grow to about 348 M, while Enterprise Value is likely to drop about 155.8 M.

AngioDynamics Total Revenue

249.71 Million

Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.1 M, Interest Expense of 1.7 M or Total Revenue of 249.7 M, as well as many indicators such as Price To Sales Ratio of 2.44, Dividend Yield of 0.0 or PTB Ratio of 2.16. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules.

Build AI portfolio with AngioDynamics Stock

Check out the analysis of AngioDynamics Correlation against competitors.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

AngioDynamics Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Common Stock Shares Outstanding

30.6 M

47.1 M

35.4 M

Slightly volatile

Total Assets

516.3 M

322.2 M

574.6 M

Slightly volatile

Short and Long Term Debt Total

4.3 M

4.5 M

74.6 M

Slightly volatile

Other Current Liabilities

51.8 M

49.3 M

32 M

Slightly volatile

Total Current Liabilities

52.3 M

87.6 M

64.9 M

Slightly volatile

Property Plant And Equipment Net

34.3 M

37.1 M

40 M

Pretty Stable

Accounts Payable

19.7 M

38.3 M

24.7 M

Slightly volatile

Cash

47.9 M

64.3 M

51.9 M

Slightly volatile

Non Current Assets Total

122.2 M

128.6 M

400.6 M

Slightly volatile

Other Assets

59.4 M

56.6 M

30 M

Slightly volatile

Long Term Debt

58.7 M

57.3 M

77.5 M

Slightly volatile

Cash And Short Term Investments

62.6 M

64.3 M

54.3 M

Slightly volatile

Net Receivables

39.9 M

49.6 M

45.3 M

Pretty Stable

Common Stock Total Equity

308.9 K

439.3 K

353 K

Slightly volatile

Liabilities And Stockholders Equity

516.3 M

322.2 M

574.6 M

Slightly volatile

Non Current Liabilities Total

22.9 M

24.1 M

94.8 M

Slightly volatile

Inventory

44.1 M

71.3 M

52.4 M

Slightly volatile

Other Current Assets

7.6 M

8.4 M

6.8 M

Pretty Stable

Other Stockholder Equity

444.7 M

705.9 M

519.7 M

Slightly volatile

Total Liabilities

128 M

111.8 M

162.8 M

Slightly volatile

Property Plant And Equipment Gross

124.9 M

118.9 M

62.7 M

Slightly volatile

Total Current Assets

155.2 M

193.6 M

160 M

Slightly volatile

Short Term Debt

2 M

2.1 M

9.4 M

Slightly volatile

Intangible Assets

110.6 M

79.5 M

135.4 M

Slightly volatile

Common Stock

319.2 K

442.8 K

354.2 K

Slightly volatile

Property Plant Equipment

34.9 M

51 M

43.1 M

Very volatile

Non Currrent Assets Other

13.9 M

12 M

17.1 M

Pretty Stable

Other Liabilities

32.6 M

20 M

29.3 M

Pretty Stable

Long Term Debt Total

69.2 M

44.8 M

85 M

Slightly volatile

Capital Surpluse

600.4 M

689.1 M

558.6 M

Slightly volatile

Non Current Liabilities Other

13.4 M

15.2 M

18.3 M

Pretty Stable

Deferred Long Term Asset Charges

8.9 M

9.4 M

13.6 M

Slightly volatile

Short and Long Term Debt

4 M

4.3 M

39.2 M

Slightly volatile

Net Invested Capital

264.5 M

164.7 M

416 M

Slightly volatile

Net Working Capital

85.6 M

82.9 M

95.6 M

Very volatile

Capital Stock

417.2 K

442.8 K

381.8 K

Slightly volatile

AngioDynamics Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

19.1 M

29.7 M

25.2 M

Slightly volatile

Total Revenue

249.7 M

336.4 M

299.9 M

Pretty Stable

Gross Profit

128.5 M

181.4 M

149.9 M

Slightly volatile

Other Operating Expenses

258.7 M

382.3 M

320 M

Slightly volatile

Research Development

22.2 M

30.2 M

26.2 M

Slightly volatile

Cost Of Revenue

110.2 M

155 M

134.6 M

Pretty Stable

Total Operating Expenses

148.6 M

227.3 M

185.5 M

Slightly volatile

Selling General Administrative

29 M

48.4 M

32.4 M

Slightly volatile

Selling And Marketing Expenses

77.7 M

118.6 M

82.6 M

Slightly volatile

Non Recurring

30.9 M

37.4 M

27.8 M

Pretty Stable

Interest Income

775.5 K

816.3 K

2.3 M

Slightly volatile

Discontinued Operations

87.5 M

83.4 M

46.2 M

Slightly volatile

Reconciled Depreciation

29 M

29.7 M

26.2 M

Slightly volatile

Extraordinary Items

42 M

83.4 M

43.9 M

Slightly volatile

AngioDynamics Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Begin Period Cash Flow

45.4 M

87.5 M

52.5 M

Slightly volatile

Depreciation

19.1 M

29.7 M

24.3 M

Slightly volatile

Capital Expenditures

6.7 M

5.1 M

5.9 M

Pretty Stable

End Period Cash Flow

47.9 M

64.3 M

51.9 M

Slightly volatile

Stock Based Compensation

8.1 M

11.2 M

7.3 M

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Price To Sales Ratio

2.44

1.64

1.8607

Pretty Stable

PTB Ratio

2.16

2.06

1.4227

Slightly volatile

Days Sales Outstanding

68.82

61.91

57.4385

Pretty Stable

Book Value Per Share

3.82

4.02

11.582

Slightly volatile

Stock Based Compensation To Revenue

0.0194

0.0301

0.0242

Slightly volatile

Capex To Depreciation

0.19

0.2

0.5522

Slightly volatile

PB Ratio

2.16

2.06

1.4227

Slightly volatile

EV To Sales

2.37

1.42

1.8836

Slightly volatile

Inventory Turnover

2.04

1.96

2.5341

Pretty Stable

Days Of Inventory On Hand

164

193

149

Very volatile

Payables Turnover

7.14

4.66

6.0119

Pretty Stable

Sales General And Administrative To Revenue

0.08

0.13

0.1039

Slightly volatile

Research And Ddevelopement To Revenue

0.0704

0.0807

0.0861

Slightly volatile

Capex To Revenue

0.0167

0.0176

0.0227

Slightly volatile

Cash Per Share

2.34

1.57

1.9176

Pretty Stable

Days Payables Outstanding

48.96

81.13

66.5981

Pretty Stable

Intangibles To Total Assets

0.38

0.22

0.5342

Slightly volatile

Current Ratio

4.2

2.54

3.1095

Slightly volatile

Receivables Turnover

5.18

6.1

6.576

Very volatile

Shareholders Equity Per Share

3.82

4.02

11.582

Slightly volatile

Debt To Equity

0.0217

0.0207

0.1466

Slightly volatile

Capex Per Share

0.12

0.13

0.1867

Slightly volatile

Revenue Per Share

6.02

6.42

8.33

Slightly volatile

Interest Debt Per Share

0.1

0.11

2.189

Slightly volatile

Debt To Assets

0.0163

0.0171

0.1048

Slightly volatile

Graham Number

23.22

22.12

17.1228

Slightly volatile

Operating Cycle

233

255

206

Very volatile

Price Book Value Ratio

2.16

2.06

1.4227

Slightly volatile

Days Of Payables Outstanding

48.96

81.13

66.5981

Pretty Stable

Company Equity Multiplier

1.45

1.38

1.3866

Slightly volatile

Long Term Debt To Capitalization

0.2

0.13

0.1365

Pretty Stable

Total Debt To Capitalization

0.0246

0.0259

0.1208

Slightly volatile

Debt Equity Ratio

0.0217

0.0207

0.1466

Slightly volatile

Quick Ratio

3.12

1.6

2.2311

Slightly volatile

Cash Ratio

1.23

0.84

1.1296

Pretty Stable

Cash Conversion Cycle

165

151

137

Pretty Stable

Days Of Inventory Outstanding

164

193

149

Very volatile

Days Of Sales Outstanding

68.82

61.91

57.4385

Pretty Stable

Price To Book Ratio

2.16

2.06

1.4227

Slightly volatile

Fixed Asset Turnover

6.46

8.15

7.9928

Slightly volatile

Debt Ratio

0.0163

0.0171

0.1048

Slightly volatile

Price Sales Ratio

2.44

1.64

1.8607

Pretty Stable

Asset Turnover

0.7

1.2

0.599

Slightly volatile

Gross Profit Margin

0.58

0.62

0.517

Pretty Stable

Price Fair Value

2.16

2.06

1.4227

Slightly volatile

AngioDynamics Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

348 M

228.2 M

479.8 M

Pretty Stable

Enterprise Value

155.8 M

164 M

465.4 M

Slightly volatile

AngioDynamics Fundamental Market Drivers

	Forward Price Earnings	96.1538
	Cash And Short Term Investments	55.9 M

AngioDynamics Upcoming Events

	4th of April 2024 Upcoming Quarterly Report	View
	10th of July 2024 Next Financial Report	View
	29th of February 2024 Next Fiscal Quarter End	View
	10th of July 2024 Next Fiscal Year End	View
	30th of November 2023 Last Quarter Report	View
	31st of May 2023 Last Financial Announcement	View

About AngioDynamics Financial Statements

AngioDynamics investors utilize fundamental indicators, such as revenue or net income, to predict how AngioDynamics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Current Deferred Revenue	-17 M	-16.1 M
Total Revenue	336.4 M	249.7 M
Cost Of Revenue	155 M	110.2 M
Stock Based Compensation To Revenue	0.03	0.02
Sales General And Administrative To Revenue	0.13	0.08
Research And Ddevelopement To Revenue	0.08	0.07
Capex To Revenue	0.02	0.02
Revenue Per Share	6.42	6.02
Ebit Per Revenue	(0.16)	(0.15)

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving together with AngioDynamics Stock

0.68

2DR

Inspire Medical Systems Earnings Call This Week

Pair Corr

Moving against AngioDynamics Stock

0.55	IMDX	Insight Molecular Symbol Change	Pair Corr
0.51	4DX	4DMEDICAL	Pair Corr
0.47	AMS	Advanced Medical Sol	Pair Corr
0.43	QIPT	Quipt Home Medical Earnings Call This Week	Pair Corr
0.41	TRLS	Trellus Health plc	Pair Corr

The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.

The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:

How To Invest In AngioDynamics

Details

Is AngioDynamics Stock a good investment?

Details

What is AngioDynamics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of AngioDynamics Correlation against competitors.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Will Health Care Equipment & Supplies sector continue expanding? Could AngioDynamics diversify its offerings? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AngioDynamics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Earnings Share

(0.67)

Revenue Per Share

7.466

Quarterly Revenue Growth

0.09

Return On Assets

(0.05)

Return On Equity

(0.15)

Investors evaluate AngioDynamics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating AngioDynamics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause AngioDynamics' market price to deviate significantly from intrinsic value.

Understanding that AngioDynamics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AngioDynamics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, AngioDynamics' market price signifies the transaction level at which participants voluntarily complete trades.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

AngioDynamics Financial Statements From 2010 to 2026

AngioDynamics Total Revenue

249.71 Million

AngioDynamics Balance Sheet

AngioDynamics Income Statement

AngioDynamics Cash Flow Statement

Financial Ratios

AngioDynamics Valuation Data

AngioDynamics Fundamental Market Drivers

AngioDynamics Upcoming Events

About AngioDynamics Financial Statements

Pair Trading with AngioDynamics

Moving together with AngioDynamics Stock

Moving against AngioDynamics Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY